These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20607804)

  • 21. Primary HPV Screening vs Cotesting for Cervical Cancer.
    Brakebill A; Morgan A; Lieberman RW
    JAMA; 2023 Dec; 330(21):2121. PubMed ID: 38051332
    [No Abstract]   [Full Text] [Related]  

  • 22. Adding a test for human papillomavirus DNA to cervical-cancer screening.
    Wright TC; Schiffman M
    N Engl J Med; 2003 Feb; 348(6):489-90. PubMed ID: 12571255
    [No Abstract]   [Full Text] [Related]  

  • 23. Primary HPV Screening vs Cotesting for Cervical Cancer-Reply.
    Perkins RB; Wentzensen N; Schiffman M
    JAMA; 2023 Dec; 330(21):2121-2122. PubMed ID: 38051330
    [No Abstract]   [Full Text] [Related]  

  • 24. Human papillomavirus testing for primary cervical cancer screening: is it time to abandon Papanicolaou testing?
    Feldman S
    JAMA Intern Med; 2014 Oct; 174(10):1539-40. PubMed ID: 25069413
    [No Abstract]   [Full Text] [Related]  

  • 25. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
    Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Have a Pap smear!'--doctors, their clients, and opportunistic cervical cancer screening.
    Chingang LC; Bischof U; Andall-Brereton G; Razum O
    Int J STD AIDS; 2005 Mar; 16(3):233-6. PubMed ID: 15829024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
    Printz C
    Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
    [No Abstract]   [Full Text] [Related]  

  • 29. HPV testing. Visible expectations and hidden realities.
    Federschneider JM; Crum CP
    Am J Clin Pathol; 2003 Oct; 120(4):483-4. PubMed ID: 14560559
    [No Abstract]   [Full Text] [Related]  

  • 30. New tests for cervical cancer screening.
    Nuovo J; Melnikow J; Howell LP
    Am Fam Physician; 2001 Sep; 64(5):780-6. PubMed ID: 11563569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
    McCaffery K; Irwig L
    J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HPV-tests as suitable complement to cytological screening].
    Rubinstein E
    Lakartidningen; 1999 May; 96(18):2195. PubMed ID: 10377654
    [No Abstract]   [Full Text] [Related]  

  • 33. Human papillomavirus and cervical disease in adolescents.
    Guido R
    Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regular, routine screening key to keeping cervical cancer rates on the decline.
    Simmons S
    Nurse Pract; 2010 Jul; 35(7):18-9. PubMed ID: 20555239
    [No Abstract]   [Full Text] [Related]  

  • 35. [Human papillomavirus testing. Important to differ between screening and diagnostics].
    Fomsgaard A
    Ugeskr Laeger; 2002 Mar; 164(13):1831; author reply 1831. PubMed ID: 11957447
    [No Abstract]   [Full Text] [Related]  

  • 36. Advances in cervical screening technology.
    Stoler MH
    Mod Pathol; 2000 Mar; 13(3):275-84. PubMed ID: 10757338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New guidelines for prevention of cervix cancer. ARG report on investigation and treatment of abnormal cytological smears].
    Strander B; Elfgren K; Andrae B
    Lakartidningen; 2011 Mar 9-15; 108(10):533-5. PubMed ID: 21744553
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
    Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical cancer screening: from the Papanicolaou smear to the vaccine era.
    Crum CP; Abbott DW; Quade BJ
    J Clin Oncol; 2003 May; 21(10 Suppl):224s-230s. PubMed ID: 12743139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.